TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 46 filers reported holding TRACON PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $579,000 | -16.5% | 346,719 | 0.0% | 0.03% | -19.4% |
Q2 2022 | $693,000 | -24.0% | 346,719 | 0.0% | 0.04% | +38.5% |
Q1 2022 | $912,000 | -5.0% | 346,719 | +0.0% | 0.03% | +36.8% |
Q4 2021 | $960,000 | -28.5% | 346,718 | 0.0% | 0.02% | +18.8% |
Q3 2021 | $1,342,000 | -40.4% | 346,718 | 0.0% | 0.02% | -44.8% |
Q2 2021 | $2,250,000 | -92.1% | 346,718 | 0.0% | 0.03% | -95.5% |
Q1 2021 | $28,535,000 | +603.4% | 346,718 | 0.0% | 0.64% | +498.1% |
Q4 2020 | $4,057,000 | +126.3% | 346,718 | 0.0% | 0.11% | +40.8% |
Q3 2020 | $1,793,000 | +163.7% | 346,718 | 0.0% | 0.08% | +181.5% |
Q2 2020 | $680,000 | +15.4% | 346,718 | 0.0% | 0.03% | -12.9% |
Q1 2020 | $589,000 | – | 346,718 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 2,518,371 | $16,344,000 | 2.72% |
Ikarian Capital, LLC | 2,716,840 | $17,631,000 | 1.42% |
Telemetry Investments, L.L.C. | 40,000 | $260,000 | 0.36% |
ACT CAPITAL MANAGEMENT, LLC | 28,500 | $185,000 | 0.10% |
Vigilare Wealth Management | 17,000 | $110,000 | 0.07% |
X-Square Capital, LLC | 20,973 | $136,000 | 0.06% |
BOOTHBAY FUND MANAGEMENT, LLC | 294,031 | $1,908,000 | 0.06% |
Johnson & Johnson Innovation - JJDC, Inc. | 84,003 | $545,000 | 0.06% |
NEA Management Company, LLC | 346,718 | $2,250,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 36,370 | $236,000 | 0.03% |